logo
Share SHARE
FONT-SIZE Plus   Neg

HP Gets $221 Mln, 5-year Medicaid Contract Extension From Wisconsin

HP (HPQ: Quote) Friday said it has signed a five-year Medicaid contract extension with Wisconsin Department of Health Services for $221 million. Under this, HP will help Wisconsin continue to meet federal Medicaid requirements while helping to reduce costs, improve service and maintain program stability. HP's responsibilities as Wisconsin's fiscal agent will be to provide all systems work and management of a decision support system and data warehouse. The company said that it already manages the state's immunization registry program and will manage a local call center, financial and federal reporting, and support for the state's drug rebate and estate recovery programs.

Further, HP will conduct a system-wide technology refresh with HP Superdome 2 servers, helping the agency to address its workload cost effectively.

The company stated, "The HP team will continue to provide Wisconsin with a flexible, reliable and cost- effective MMIS that's ready for the future and helps enable the state to maintain its quality Medicaid program." The HP interChange MMIS is a multipayer system that has been implemented in 13 states over the past decade.

Friday, the stock closed at $25.21 on the NYSE.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Chipotle Mexican Grill Inc. (CMG) on Monday reported a surge in profit for the first quarter, as revenues climbed 20 percent on new restaurant openings and strong same-restaurant sales. Earnings for the quarter trounced Wall Street expectations, but revenues fell short of estimates, hurt largely... Yahoo reported a plunge in profit, hurt by lower prices for display ads as well as one-time charges. Its results fell short of Street estimates, denoting the challenges CEO Marissa Mayer faces in implementing her turnaround plans at the Internet company. Amgen Inc. (AMGN) on Tuesday reported a surge in profit for the first quarter, as revenues grew 11 percent on better pricing and strong demand with research costs falling. Both earnings and revenues for the quarter trumped analysts' estimates. Moving ahead, the drug maker raised its outlook for the full...
comments powered by Disqus
RELATED NEWS
Trade HPQ now with 
Follow RTT